Study validates disc diffusion method to distinguish Salmonella vaccine strains

A newly published study in Veterinary Sciences examines a practical diagnostic problem in poultry health: how to reliably tell a live bivalent Salmonella vaccine strain from a true field isolate when a flock tests positive. The paper, titled “Reliable Differentiation of a Bivalent Live Salmonella Vaccine and Field Strains: Multi-Supplier Validation of a Disc Diffusion Method,” evaluates a disc diffusion approach intended to support that distinction across suppliers. The focus is on Salmonella Enteritidis and Salmonella Typhimurium, the two serovars most closely tied to poultry-associated foodborne risk. (efsa.europa.eu)

The issue isn't academic. Live Salmonella vaccination has been part of poultry control programs for decades, especially in breeders and laying hens, because it can reduce colonization and shedding and support public health goals. But once live vaccines are in use, surveillance gets more complicated: a positive bacteriology result may reflect vaccine strain recovery rather than circulation of a wild-type field strain. EU rules explicitly address that point, stating that live vaccines should not be used unless the manufacturer provides an appropriate method to distinguish bacteriologically wild-type Salmonella from vaccine strains. (eur-lex.europa.eu)

That regulatory backdrop helps explain why differentiation methods have become an important niche in poultry diagnostics. A 2024 Veterinary Sciences paper from Sciensano and Elanco described PCR assays for distinguishing AviPro Salmonella vaccine strains from wild-type Enteritidis and Typhimurium isolates, noting that phenotypic antimicrobial resistance testing had been the routine approach for more than 20 years and that some labs wanted PCR for operational reasons. The new disc diffusion validation appears to sit in that same DIVA-style space, but with an emphasis on a simpler phenotypic workflow and multi-supplier reproducibility. (mdpi.com)

The broader disease context remains pressing. EFSA says salmonellosis was the second most reported gastrointestinal zoonosis in the EU in 2023, with 77,486 human cases, and it continues to describe Salmonella as a major foodborne hazard linked to poultry meat and eggs. EFSA also notes that Enteritidis is responsible for the highest number of egg-borne outbreaks in the EU, while poultry control programs remain a core part of the bloc's One Health strategy. In that setting, diagnostic methods that preserve both vaccine use and surveillance specificity are more than a lab convenience. (efsa.europa.eu)

I didn't find substantial independent expert commentary on this specific paper, which suggests the story is more of a technical validation update than a market-moving policy event. Still, the surrounding literature points to sustained industry demand for workable differentiation tools. Recent publications have described PCR assays, chromogenic media approaches, and other DIVA-style methods for separating vaccine strains from field isolates, reinforcing that this is an active operational need rather than a one-off academic exercise. (mdpi.com)

Why it matters: For veterinary professionals working in poultry production, the practical value is clearer decision-making after a positive Salmonella finding. If a lab can confidently distinguish vaccine-origin isolates from field strains using a validated, accessible method, that can reduce unnecessary alarm, support compliance, and help avoid costly downstream consequences tied to misinterpretation. It also helps protect confidence in live vaccination as a control tool at a time when Salmonella remains a public health and food chain concern. For practices advising integrators, hatcheries, breeder farms, or layer operations, the story is really about diagnostic clarity supporting better flock management. (eur-lex.europa.eu)

What to watch: The next question is adoption. Watch for whether national reference labs, commercial poultry labs, or vaccine manufacturers incorporate the disc diffusion protocol into routine workflows, and whether future guidance positions it alongside PCR-based options rather than as a replacement. If uptake follows, the method could become part of the standard diagnostic toolkit for vaccinated poultry systems. That last point is an inference based on the existing regulatory requirement for differentiation and the steady stream of recent DIVA-method publications. (eur-lex.europa.eu)